BPC-157 is a synthetic peptide derived from a fragment of body protection compound studied for its effects on healing pathways, which places it in a separate research category from AOD-9604s beta-3 adrenergic and lipolytic activity
Weeks 1 through 4: 0.25mg per week (1mg total used over 4 weeks) Weeks 5 through 8: 0.5mg per week (2mg total used over 4 weeks) Weeks 9 through 12: 1.0mg per week (4mg total used over 4 weeks) Weeks 13 through 16: 1.7mg per week (6.8mg total used over 4 weeks) Week 17 onward: 2.4mg per week (maintenance dose) During the first four weeks at 0.25mg weekly, you use only 1mg from your 10mg vial
This is the second lot of loading doses Ive had in the last 2 years
If left untreated, it can lead to an increased risk of serious health problems, including permanent nerve damage
Additionally, five individuals who had mild COVID-19 but did not exhibit any signs of VCD or other neuropsychological sequelae that could be related to the infection at the recruitment and at six- and 12-month follow-ups were included as controls
A clinician can run specific tests to determine if injections would work better for you